Randomized, Phase II study of pemetrexed plus bevacizumab versus pemetrexed alone after treatment with cisplatin, pemetrexed, and bevacizumab in advanced non‐squamous, non‐small cell lung cancer: TORG (thoracic oncology research group) 1321.

Autor: Kasai, Takashi1 (AUTHOR) takasai@tochigi‐cc.jp, Mori, Kiyoshi2 (AUTHOR), Nakamura, Yoichi1 (AUTHOR), Seki, Nobuhiko3 (AUTHOR), Ichikawa, Yasuko3 (AUTHOR), Saito, Haruhiro4 (AUTHOR), Kondo, Tetsuro4 (AUTHOR), Nishikawa, Kazuo5 (AUTHOR), Otsu, Satoshi5 (AUTHOR), Bessho, Akihiro6 (AUTHOR), Tanaka, Hiroshi7 (AUTHOR), Yamaguchi, Hiroyuki8 (AUTHOR), Kaburagi, Takayuki9 (AUTHOR), Imai, Hisao10,11 (AUTHOR), Mori, Keita12 (AUTHOR), Ohtake, Junya13 (AUTHOR), Okamoto, Hiroaki14 (AUTHOR)
Zdroj: Cancer Medicine. Jul2023, Vol. 12 Issue 14, p14988-14999. 12p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje